Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain

Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain

NCT02362672 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain

NCT03176121 ·Status: COMPLETED ·Phase: PHASE4

Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain

NCT02824276 ·Status: COMPLETED ·Phase: PHASE1

Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain

NCT00549042 ·Status: COMPLETED ·Phase: PHASE3

Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain

NCT02741076 ·Status: TERMINATED ·Phase: PHASE4

Real World Study of Oxycodone Sustained-release Tablets for Patients With Moderate to Severe Cancer Pain

NCT05962294 ·Status: UNKNOWN

A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

NCT00626600 ·Status: TERMINATED ·Phase: PHASE3

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

NCT02321397 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone

NCT00945919 ·Status: UNKNOWN ·Phase: NA

Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects

NCT01959204 ·Status: COMPLETED ·Phase: PHASE4

OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models

NCT00271973 ·Status: COMPLETED ·Phase: PHASE4

Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

NCT00228605 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

NCT00214955 ·Status: COMPLETED ·Phase: PHASE3

Open Label Assessment of Long-Term Safety and Utility

NCT00904449 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

NCT00390039 ·Status: COMPLETED ·Phase: PHASE3

Endogenous Opioid Response to Injections

NCT06666621 ·Status: RECRUITING ·Phase: PHASE4

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

NCT04218409 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms

NCT05142267 ·Status: RECRUITING ·Phase: NA

A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.

NCT00261495 ·Status: COMPLETED ·Phase: PHASE3

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

NCT00485225 ·Status: COMPLETED ·Phase: PHASE2

3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain

NCT05265052 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects

NCT00765856 ·Status: TERMINATED ·Phase: PHASE3

Evaluation of Risk Minimization, Assessment and Outcomes in Patients With Chronic Pain Taking Avinza

NCT00640042 ·Status: COMPLETED ·Phase: PHASE4

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

NCT00930943 ·Status: COMPLETED ·Phase: PHASE4

A Double-blind Study of Controlled Release OROS Hydromorphone Compared to Placebo in Patients With Chronic Osteoarthritis (OA) Pain

NCT00631319 ·Status: COMPLETED ·Phase: PHASE3